Brooke E. Rothstein

Dermatology

5340 S Quebec St Ste 300
Greenwood Village, CO 80111

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Practice Variation in Utilization of Flap or Graft Reconstruction Among Veterans Affairs Surgeons After Extirpation of Keratinocyte Carcinoma on the Nose.

Practice Variation in Utilization of Flap or Graft Reconstruction Among Veterans Affairs Surgeons After Extirpation of Keratinocyte Carcinoma on the Nose.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Published: July 09, 2021

An Updated Work-Up for Patients With Xanthelasma Palpebrarum.

An Updated Work-Up for Patients With Xanthelasma Palpebrarum.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Published: May 14, 2021

Well-differentiated squamous cell carcinoma as a complication of the 1927-nm thulium nonablative fractional laser.

Well-differentiated squamous cell carcinoma as a complication of the 1927-nm thulium nonablative fractional laser.

Journal: Journal of cosmetic dermatology

Published: August 23, 2020

Total Margin-Controlled Excision is Superior to Standard Excision for Keratinocyte Carcinoma on the Nose: A Veterans Affairs Nested Cohort Study.

Total Margin-Controlled Excision is Superior to Standard Excision for Keratinocyte Carcinoma on the Nose: A Veterans Affairs Nested Cohort Study.

Journal: Annals of surgical oncology

Published: August 02, 2020

Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial.

Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial.

Journal: Journal of the American Academy of Dermatology

Published: July 01, 2019

Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa.

Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa.

Journal: The British journal of dermatology

Published: February 26, 2019

Direct and indirect patient costs of dermatology clinic visits and their impact on access to care and provider preference.

Direct and indirect patient costs of dermatology clinic visits and their impact on access to care and provider preference.

Journal: Cutis

Published: January 24, 2018

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib.

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib.

Journal: Journal of the American Academy of Dermatology

Published: September 28, 2016

Apremilast and Secukinumab Combined Therapy in a Patient With Recalcitrant Plaque Psoriasis.

Apremilast and Secukinumab Combined Therapy in a Patient With Recalcitrant Plaque Psoriasis.

Journal: Journal of drugs in dermatology : JDD

Published: May 12, 2016

Secukinumab for treating plaque psoriasis.

Secukinumab for treating plaque psoriasis.

Journal: Expert opinion on biological therapy

Published: November 19, 2015

Loss of primary cilia in melanoma cells is likely independent of proliferation and cell cycle progression.

Loss of primary cilia in melanoma cells is likely independent of proliferation and cell cycle progression.

Journal: The Journal of investigative dermatology

Published: January 29, 2015

HIPAA, dermatology images, and the law.

HIPAA, dermatology images, and the law.

Journal: Seminars in cutaneous medicine and surgery

Published: May 08, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026